Alberto Ballestrero

Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents

Gabriele Zoppoli, Marie Regairaz, Elisabetta Leo et al. · Proceedings of the National Academy of Sciences · 2012 · 356 citations · Full text

Tumor Biology, Oncology, Oncogenic Agent +15

Fasting-mimicking diet and hormone therapy induce breast cancer regression

Irene Caffa, V. Spagnolo, Claudio Vernieri et al. · Nature · 2020 · 335 citations · Full text

Obesity, Nutrition, Appetite Control +6

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini et al. · The Lancet Oncology · 2020 · 309 citations · Full text

Oncology, Medicine, Colorectal Cancer +8

Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro

Paolo Spallarossa, Silvano Garibaldi, Paola Altieri et al. · Journal of Molecular and Cellular Cardiology · 2004 · 291 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +9

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase

Paolo Spallarossa, Paola Altieri, Silvia Garibaldi et al. · Cardiovascular Research · 2005 · 184 citations